| Autor: |
Melissa Andreia de Moraes Silva, Mateus Alves Borges Cristino, Ricardo Jayme Procópio |
| Jazyk: |
English<br />Portuguese |
| Rok vydání: |
2021 |
| Předmět: |
|
| Zdroj: |
Revista Ciências em Saúde, Vol 11, Iss 2 (2021) |
| Druh dokumentu: |
article |
| ISSN: |
2236-3785 |
| DOI: |
10.21876/rcshci.v11i2.1165 |
| Popis: |
Vaccines against COVID-19 from Moderna Biotech Spain, SL (COVID-19 Vaccine Moderna – mRNA technology), AstraZeneca (Oxford/Astrazeneca Vaccine - ChAdOx1 - adenovirus vector technology) and Janssen-Cilag International NV (COVID-19 Vaccine) Janssen - Ad.26.COV2.S - adenovirus vector technology) used in Europe, the United States and Brazil has presented severe thrombotic adverse reactions. The recorded thrombosis occurred in unusual sites, such as the sagittal venous sinus. |
| Databáze: |
Directory of Open Access Journals |
| Externí odkaz: |
|
